An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer-Reference-Cited by-同舟云学术

An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer

Published:2024-02 Issue: Volume:265 Page:116114
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Myers Samuel H.,Poppi Laura,Rinaldi Francesco,Veronesi Marina^ORCID,Ciamarone Andrea,Previtali Viola,Bagnolini Greta,Schipani Fabrizio,Ortega Martínez Jose Antonio,Girotto Stefania,Di Stefano Giuseppina,Farabegoli Fulvia,Walsh Naomi,De Franco Francesca,Roberti Marinella^ORCID,Cavalli Andrea

Funder

Airc Italian Foundation for Cancer Research

Istituto Italiano di Tecnologia

Associazione Italiana per la Ricerca sul Cancro

Università di Bologna

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference58 articles.

1. DNA damage and its role in cancer therapeutics;Moon;Int. J. Mol. Sci.,2023

2. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy;Huang;Signal Transduct. Targeted Ther.,2021

3. Population frequency of germline BRCA1/2 mutations;Maxwell;J. Clin. Oncol.,2016

4. Synthetic lethality in pancreatic cancer: discovery of a new RAD51-BRCA2 small molecule disruptor that inhibits homologous recombination and synergizes with olaparib;Bagnolini;J. Med. Chem.,2020

5. Synthetic lethality through the lens of medicinal chemistry;Myers;J. Med. Chem.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in the Synthesis of Triazolopyrimidines;Current Organic Chemistry;2024-12

2. An update on small molecule compounds targeting synthetic lethality for cancer therapy;European Journal of Medicinal Chemistry;2024-11

3. New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives;Journal of Medicinal Chemistry;2024-07-02